Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Analysis of Egyptian MTA, Biodentine, and Calcium Hydroxide as Indirect Pulp Capping Materials in Permanent Teeth. (A 6m Randomized Clinical Trial)

NCT06683833 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT06683833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06683833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Analysis of Egyptian MTA, Biodentine, and Calcium Hydroxide as Indirect Pulp Capping Materials in Permanent Teeth. (A 6m Randomized Clinical Trial)
Lead sponsor
Cairo University
Phase
Phase 4
Overall status
Recruiting
Start date
September 3, 2025
Completion date
July 3, 2026
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biodentine, calcium hydroxide, deep caries, indirect pulp capping, mineral trioxide aggregate (mta), patient reported outcome measures